| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.48 | 0.0004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |